TeleHealth Services launches AI-driven patient engagement platform

TeleHealth Services unveiled iCare Navigator, an interactive, artificial intelligence-powered patient engagement platform that includes a virtual health coach.

Advertisement

The solution uses avatars that engage patients to help them improve their health and change unhealthy behaviors. Technology already in use in hospitals, such as EMRs, patient televisions, and bedside tablets, can scale the platform.

TeleHealth Services is working with healthcare facilities to implement pilot programs for the iCare Navigator.

“Our goal in developing iCare Navigator was to create the first interactive patient care system that uses a combination of empathy, personal motivation, game theory, family involvement and artificial intelligence to help patients be more receptive to changing their health behavior,” according to TeleHealth Services Vice President of Product Development Richard Bootes.

More articles on patient engagement: 
10 consumer engagement strategies, as ranked by healthcare providers  
Patients’ perception of hospital food influenced by ordering, delivery experience 
Virtual OR tours may reduce presurgical anxiety in children, study finds

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

New language access rules are reshaping patient experience: Lessons from Denver Health and UnityPoint Health

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Dipak Patel, GLOBOTyler Gegen, MBA, FACHE, CPXP, UnityPoint HealthMaria Pamboukis, M.D. CPXP., Denver Health

Advertisement

Next Up in Patient Experience

Advertisement

Comments are closed.